Comparative Assessment of the Long-Term Effectiveness and Safety of Dapagliflozin and Empagliflozin as Add-on Therapy to Hypoglycemic Drugs in Patients with Type 2 Diabetes

Added 37 days ago (23.05.2022)

Authors: Ai-Yu Yang and Hung-Chun Chen

Journal: Journal of Diabetes Research

Google Translate

Read article